Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 May;11(5):741-7.
doi: 10.1128/JVI.11.5.741-747.1973.

Relationship of reticuloendotheliosis virus to the avian tumor viruses: nucleic acid and polypeptide composition

Relationship of reticuloendotheliosis virus to the avian tumor viruses: nucleic acid and polypeptide composition

R L Maldonado et al. J Virol. 1973 May.

Abstract

The RNA content and polypeptide composition of reticuloendotheliosis virus (REV) was compared to that of C-type RNA tumor viruses. Two RNA species with approximate sedimentation values of 64S and 4S were observed after sucrose gradient centrifugation of RNA extracted from purified REV. The high-molecular-weight RNA species of REV sedimented slightly faster than that of the Bryan strain of Rous sarcoma virus (RSV). Although these characteristics were consistent with those of other C-type RNA tumor viruses, significant differences were observed when the polypeptide composition of REV was compared with that of RSV possessing envelope determinants of Rous-associated virus RAV-2 and RAV-3. Five polypeptides of which two were glycosylated were resolved by polyacrylamide gel electrophoresis. The major nonglycosylated polypeptide of REV did not comigrate with that of RSV (RAV-2)-RSV(RAV-3). The majority of the group-specific antigen reactivity resides in this major nonglycosylated polypeptide of avian tumor viruses and comigrates when proteins of several avian tumor viruses are subjected to coelectrophoresis. This difference in the migration of the major polypeptide of REV and RSV(RAV-2)-RSV(RAV-3) may explain the absence of avian tumor virus group-specific antigen in REV.

PubMed Disclaimer

References

    1. Virology. 1966 Nov;30(3):368-74 - PubMed
    1. J Natl Cancer Inst. 1966 Dec;37(6):709-29 - PubMed
    1. J Natl Cancer Inst. 1966 Dec;37(6):731-43 - PubMed
    1. Cancer Res. 1967 Jun;27(6):1138-57 - PubMed
    1. Cancer Res. 1968 Jul;28(7):1288-99 - PubMed

MeSH terms

LinkOut - more resources